Welcome to LookChem.com Sign In|Join Free
  • or
(S)-N-Boc-L-homoserine Triethylammonium Salt is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

796072-25-8

Post Buying Request

796072-25-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

796072-25-8 Usage

Chemical Properties

Clear Colorless Oil

Check Digit Verification of cas no

The CAS Registry Mumber 796072-25-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,6,0,7 and 2 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 796072-25:
(8*7)+(7*9)+(6*6)+(5*0)+(4*7)+(3*2)+(2*2)+(1*5)=198
198 % 10 = 8
So 796072-25-8 is a valid CAS Registry Number.

796072-25-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N,N-diethylethanamine,(2S)-4-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid

1.2 Other means of identification

Product number -
Other names N-tert-Butoxycarbonyl-L-homoserine Triethylammonium Salt

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:796072-25-8 SDS

796072-25-8Relevant academic research and scientific papers

SUBSTITUTED AMINO CARBOXYLIC ACIDS

-

Page/Page column 199, (2008/06/13)

Disclosed are compounds and pharmaceutically acceptable salts of formula (I): which are useful in the treatment of metabolic disorders related to insulin resistance, leptin resistance, or hyperglycemia. Compounds of the invention include inhibitors of Protein tyrosine phosphatases, in particular Protein tyrosine phosphatase-1B (PTP-1B), that are useful in the treatment of diabetes and other PTP mediated diseases, such as cancer, neurodegenerative diseases and the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 796072-25-8